Jefferies Analyst Defends Nektar Therapeutics (NKTR) Amid 21% Stock Drop on Rezpegaldesleukin Data
· gurufocus.com
On October 01, 2026, Nektar Therapeutics (NASDAQ: NKTR) shares plunged approximately 21% to $47.90 following updated data on rezpegaldesleukin. A Jefferies anal
On October 01, 2026, Nektar Therapeutics (NASDAQ: NKTR) shares plunged approximately 21% to $47.90 following updated data on rezpegaldesleukin. A Jefferies anal...